Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study

World Journal of Hepatology

Volumn 9, Issue 29, 2017, Pages 1141-1157

  Melchart, Dieter ^a,b   Hager, Stefan ^c   Albrecht, Sabine ^c   Dai, Jingzhang ^c,d   Weidenhammer, Wolfgang ^b   Teschke, Rolf ^e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Hospital for Traditional Chinese Medicine   (Germany)

^d BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Herb induced liver injury; Herbal medicine; Liver injury; Roussel Uclaf Causality Assessment Method; Traditional Chinese Medicine

Indexed keywords

EID: 85032299039     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v9.i29.1141     Document Type: Article

References (58)

1. Ge S, He TT, Hu H. Popularity and customer preferences for overthe-counter Chinese medicines perceived by community pharmacists in Shanghai and Guangzhou: a questionnaire survey study. Chin Med 2014; 9: 22 [PMID: 25243017 DOI: 10.1186/1749-8546-9-22]
2. National Institutes of Health (NIH) and LiverTox. Chinese and other Asian herbal medicines. 2016. Accessed on 23 April 2017. Available from: URL: http://livertox.nih.gov/ChineseAndOther AsianHerbalMedicines.htm
3. Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol 2015; 21: 4466-4490 [PMID: 25914456 DOI: 10.3748/wjg.v21.i15.4466]
4. Teo DC, Ng PS, Tan SH, Lim AT, Toh DS, Chan SY, Cheong HH. Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014. BMC Complement Altern Med 2016; 16: 192 [PMID: 27389194 DOI: 10.1186/s12906-016-1168-z]
5. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177 [PMID: 24454289 DOI: 10.3389/fphar.2013.00177]
6. Teschke R. Traditional Chinese Medicine Induced Liver Injury. J Clin Transl Hepatol 2014; 2: 80-94 [PMID: 26357619 DOI: 10.14218/JCTH.2014.00003]
7. Kumana CR, Ng M, Lin HJ, Ko W, Wu PC, Todd D. Hepatic venoocclusive disease due to toxic alkaloid herbal tea. Lancet 1983; 2: 1360-1361 [PMID: 6139688 DOI: 10.1016/S0140-6736(83)91112-1]
8. Teschke R, Wolff A, Frenzel C, Schulze J. Review article: Herbal hepatotoxicity-an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther 2014; 40: 32-50 [PMID: 24844799 DOI: 10.1111/apt.12798]
9. Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, Wang RL, He TT, Song HB, Wang ZX, Pu SB, Ma X, Wang LF, Bai ZF, Zhao YL, Li YG, Wang JB, Xiao XH; Specialized Committee for Drug-Induced Liver Diseases, Division of Drug-Induced Diseases, Chinese Pharmacological Society. Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol 2016; 31: 1476-1482 [PMID: 26896664 DOI: 10.1111/jgh.13323]
10. Yu J, Xie J, Mao XJ, Wang MJ, Li N, Wang J, Zhaori GT, Zhao RH. Hepatoxicity of major constituents and extractions of Radix Polygoni Multiflori and Radix Polygoni Multiflori Praeparata. J Ethnopharmacol 2011; 137: 1291-1299 [PMID: 21840387 DOI: 10.1016/j.jep.2011.07.055]
11. China Food and Drug Administration. Consideration of the risks of liver injury caused by Polygonum multiflorum. Accessed on May 05, 2017. Available from: URL: http://www.sda.gov.cn/WS01/CL0051/102902.html
12. Lee CH, Wang JD, Chen PC. Risk of liver injury associated with Chinese herbal products containing radix bupleuri in 639,779 patients with hepatitis B virus infection. PLoS One 2011; 6: e16064 [PMID: 21264326 DOI: 10.1371/journal.pone.0016064]
13. Woo HJ, Kim HY, Choi ES, Cho YH, Kim Y, Lee JH, Jang E. Druginduced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center. Phytomedicine 2015; 22: 1201-1205 [PMID: 26598920 DOI: 10.1016/j.phymed.2015.10.002]
14. Dag MS, Aydinli M, Oztürk ZA, Türkbeyler IH, Koruk I, Savas MC, Koruk M, Kadayifçi A. Drug-and herb-induced liver injury: a case series from a single center. Turk J Gastroenterol 2014; 25: 41-45 [PMID: 24918129 DOI: 10.5152/tjg.2014.4486]
15. Ou P, Chen Y, Li B, Zhang M, Liu X, Li F, Li Y, Chen C, Mao Y, Chen J. Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital. Springerplus 2015; 4: 802 [PMID: 26702391 DOI: 10.1186/s40064-015-1600-8]
16. Teschke R, Wolff A, Frenzel C, Schulze J. Letter: Herbal hepaotoxicity-an update on traditional Chinese medicine preparations; authors' reply. Aliment Pharmacol Ther 2014; 40: 738-740 [PMID: 25123394 DOI: 10.1111/apt.12887]
17. Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol 2015; 6: 72 [PMID: 25954198 DOI: 10.3389/fphar.2015.00072]
18. Frenzel C, Teschke R. Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. Int J Mol Sci 2016; 17: pii: E588 [PMID: 27128912 DOI: 10.3390/ijms17050588]
19. Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines 2016; 3:18. [DOI: 10.3390/medicines3030018]
20. Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002; 252: 107-113 [PMID: 12190885 DOI: 10.1046/j.1365-2796.2002.00999.x]
21. Shaw D. Toxicological risks of Chinese herbs. Planta Med 2010; 76: 2012-2018 [PMID: 21077025 DOI: 10.1055/s-0030-1250533]
22. Efferth T, Kaina B. Toxicities by herbal medicines with emphasis to traditional Chinese medicine. Curr Drug Metab 2011; 12: 989-996 [PMID: 21892916 DOI: 10.2174/138920011798062328]
23. Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, Chan K, Shaw D, Duez P. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J Ethnopharmacol 2012; 140: 519-525 [PMID: 22374080 DOI: 10.1016/j.jep.2012.01.058]
24. Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol 2013; 69: 295-307 [PMID: 22843016 DOI: 10.1007/s00228-012-1353-z]
25. Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci 2015; 17: 14 [PMID: 26712744 DOI: 10.3390/ijms17010014]
26. Teschke R, Danan G. Causality assessment methods in drug-induced liver injury. In: Drug-induced Liver Toxicity. Editors: Minjun Chen and Yvonne Will. Series: Methods in Pharmacology and Toxicology/Y. James Kang David C. Casey. Berlin Germany: Springer Protocols, Springer, 2017
27. Nin Chau T, Cheung WI, Ngan T, Lin J, Lee KW, Tat Poon W, Leung VK, Mak T, Tse ML; Hong Kong Herb-Induced Liver Injury Network (HK-HILIN). Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM). Clin Toxicol (Phila) 2011; 49: 34-39 [PMID: 21114414 DOI: 10.3109/15563650.2010.537662]
28. Zhang P, Ye Y, Yang X, Jiao Y. Systematic Review on Chinese Herbal Medicine Induced Liver Injury. Evid Based Complement Alternat Med 2016; 2016: 3560812 [PMID: 27651817 DOI: 10.1155/2016/3560812]
29. Wang J, Ma Z, Niu M, Zhu Y, Liang Q, Zhao Y, Song J, Bai Z, Zhang Y, Zhang P, Li N, Meng Y, Li Q, Qin L, Teng G, Cao J, Li B, Chen S, Li Y, Zou Z, Zhou H, Xiao X. Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum. Front Med 2015; 9: 457-467 [PMID: 26459430 DOI: 10.1007/s11684-015-0417-8]
30. Zhu Y, Liu SH, Wang JB, Song HB, Li YG, He TT, Ma X, Wang ZX, Wang-Li-ping, Zhou K, Bai YF, Zou ZS, Xiao XH. [Clinical Analysis of Drug-induced Liver Injury Caused by Polygonum multiflorum and its Preparations]. Zhongguo Zhongxiyi Jiehe Zazhi 2015; 35: 1442-1447 [PMID: 26882605]
31. Papafragkakis C, Ona MA, Reddy M, Anand S. Acute Hepatitis after Ingestion of a Preparation of Chinese Skullcap and Black Catechu for Joint Pain. Case Reports Hepatol 2016; 2016: 4356749 [PMID: 27144042 DOI: 10.1155/2016/4356749]
32. Hager S, Dai J, Fischer V, Lüthke F, Staudinger A. East Meets West: Synergy through Diversity. Forsch Komplementmed 2016; 23 Suppl 2: 3-7 [PMID: 27272152 DOI: 10.1159/000444766]
33. Chinese Pharmacopoeia Commission (ed): Pharmacopoeia of the People's Republic of China 2010, English Edition vol. I, Appendix IID A-25. Beijing: China Medical Science Press, 2010
34. Teschke R, Schulze J, Eickhoff A, Danan G. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Int J Mol Sci 2017; 18: E803 [PMID: 28398242 DOI: 10.3390/ijms18040803]
35. Weidenhammer W, Melchart D. Quality Profiling at the TCM Hospital Bad Kötzting-Examples from an Ongoing Systematic Patient Documentation. Forsch Komplementmed 2016; 23 Suppl 2: 8-15 [PMID: 27272539 DOI: 10.1159/000445009]
36. Wagner H, Bauer R, Melchart D. New Analytical Monographs on TCM Herbal Drugs for Quality Proof. Forsch Komplementmed 2016;23(Suppl 2):16-20 [PMID: 27271998 DOI: 10.1159/000444730]
37. Feng DD, Tang T, Lin XP, Yang ZY, Yang S, Xia ZA, Wang Y, Zheng P, Wang Y, Zhang CH. Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review. Neuropsychiatr Dis Treat 2016; 12: 2387-2402 [PMID: 27703356 DOI: 10.2147/NDT.S114560]
38. Melchart D, Linde K, Liao X, Hager S. Herbal treatment in a hospital for traditional Chinese medicine in Germany. Phytomedicine 1996; 3 (suppl 1): SL-128
39. Melchart D, Linde K, Weidenhammer W, Hager S, Liao J, Bauer R, Wagner H. Use of traditional drugs in a hospital of Chinese medicine in Germany. Pharmacoepidemiol Drug Saf 1999; 8: 115-120 [PMID: 15073936 DOI: 10.1002/(SICI)1099-1557(199903/04)8:23.0.CO;2-I]
40. Wagner H, Bauer R, Melchart D, Xiao PG, Staudinger A. Chromatographic fingerprint analysis of herbal medicines, vol. 1-4. Wien: Springer, 2011
41. Bauer R, Tittel G. Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies. Phytomedicine 1996; 2: 193-198 [PMID: 23194615]
42. Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, Ding Y, Duan ZP, Fu QC, Guo XY, Hu P, Hu XQ, Jia JD, Lai RT, Li DL, Liu YX, Lu LG, Ma SW, Ma X, Nan YM, Ren H, Shen T, Wang H, Wang JY, Wang TL, Wang XJ, Wei L, Xie Q, Xie W, Yang CQ, Yang DL, Yu YY, Zeng MD, Zhang L, Zhao XY, Zhuang H; Drug-induced Liver Injury (DILI) Study Group; Chinese Society of Hepatology (CSH); Chinese Medical Association (CMA). CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int 2017; 11: 221-241 [PMID: 28405790 DOI: 10.1007/s12072-017-9793-2]
43. Teschke R, Zhang L, Long H, Schwarzenboeck A, Schmidt-Taenzer W, Genthner A, Wolff A, Frenzel C, Schulze J, Eickhoff A. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Ann Hepatol 2015; 14: 7-19 [PMID: 25536637]
44. Teschke R, Frenzel C, Wolff A, Eickhoff A, Schulze J. Drug induced liver injury: accuracy of diagnosis in published reports. Ann Hepatol 2014; 13: 248-255 [PMID: 24552867]
45. Shahbaz O, Mahajan S, Lewis JH. Highlights of Drug-and Herbinduced liver injury in the Literature from 2016: How Best to Translate New Information into Clinical Practice? Expert Opin Drug Metab Toxicol 2017; 13: 935-951 [PMID: 28772086 DOI: 10.1080/1742525 5.2017.1362391]
46. Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013; 25: 1093-1098 [PMID: 23510966 DOI: 10.1097/MEG.0b013e3283603e89]
47. Teschke R, Schulze J, Eickhoff A, Wolff A, Frenzel C. Mysterious Hawaii liver disease case-Naproxen overdose as cause rather than OxyELITE Pro? J Liver Clin Res 2015; 2: 1013
48. Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann Hepatol 2016; 15: 91-109 [PMID: 26626645]
49. Teschke R, Eickhoff A. The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges. Int J Mol Sci 2016; 17:476. [PMID: 27043544 DOI: 10.3390/ijms17040476]
50. Teschke R, Eickhoff A. Suspected Liver Injury and the Dilemma of Causality. Dig Dis Sci 2017; 62: 1095-1098 [PMID: 28210906 DOI: 10.1007/s10620-016-4442-5]
51. Teschke R, Danan G. Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease. Drug Saf 2016; 39: 729-744 [PMID: 27091053 DOI: 10.1007/s40264-016-0423-z]
52. Teschke R, Danan G. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol 2017; 13: 425-438 [PMID: 27822971 DOI: 10.1080/1742525 5.2017.1252749]
53. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, Lemoine A, Hillon P. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-455 [PMID: 12143055 DOI: 10.1053/jhep.2002.34857]
54. Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol 2013; 75: 603-618 [PMID: 22670731 DOI: 10.1111/j.1365-2125.2012.04350.x]
55. Zhang ZJ, Tan QR, Tong Y, Wang XY, Wang HH, Ho LM, Wong HK, Feng YB, Wang D, Ng R, McAlonan GM, Wang CY, Wong VT. An epidemiological study of concomitant use of Chinese medicine and antipsychotics in schizophrenic patients: implication for herbdrug interaction. PLoS One 2011; 6: e17239 [PMID: 21359185 DOI: 10.1371/journal.pone.0017239]
56. Chen M, Borlak J, Tong W. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology 2013; 58: 388-396 [PMID: 23258593 DOI: 10.1002/hep.26208]
57. Melchart D, Hager S, Dai J, Weidenhammer W. Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine-A Retrospective Analysis. Forsch Komplementmed 2016; 23 Suppl 2: 21-28 [PMID: 27272353 DOI: 10.1159/000444983]
58. Yuen MF, Tam S, Fung J, Wong DK, Wong BC, Lai CL. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther 2006; 24: 1179-1186 [PMID: 17014576 DOI: 10.1111/j.1365-2036.2006.03111.x]